0001161697-24-000194.txt : 20240410
0001161697-24-000194.hdr.sgml : 20240410
20240410171534
ACCESSION NUMBER: 0001161697-24-000194
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240408
FILED AS OF DATE: 20240410
DATE AS OF CHANGE: 20240410
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tierney David S
CENTRAL INDEX KEY: 0001292636
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 24836580
MAIL ADDRESS:
STREET 1: C/O ABLE LABORATORIES, INC.
STREET 2: 6 HOLLYWOOD COURT, CN 1013
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form4.xml
FORM 4 FOR 04-08-2024
X0508
4
2024-04-08
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001292636
Tierney David S
355 ALHAMBRA CIRCLE, SUITE 801
CORAL GABLES
FL
33134
1
0
0
0
0
Common stock, par value $0.001 per share
2024-04-08
4
M
0
25000
4.01
A
373874
D
Common stock, par value $0.001 per share
2024-04-08
4
S
0
25000
15.68
D
348874
D
Options to purchase common stock
4.01
2024-04-08
4
M
0
25000
0
A
2025-01-02
Common Stock
25000
203931
D
Shares were sold on the open market to fund payment of a personal tax liability and not as a result of any disagreement with the Company.
Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.55 to $15.77 per share.
Options vested in three annual tranches beginning on January 2, 2019.
/s/ David S. Tierney
2024-04-10